NCT06154434View on ClinicalTrials.gov

Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

February 12, 2019

Study Completion Date

February 12, 2019

Conditions
Healthy Subject
Interventions
DRUG

Chlorpromazine HCl 100mg Tablets

single-dose administered after a 10-hour overnight fast.

Trial Locations (1)

Unknown

Whan In Pharm., Seoul

All Listed Sponsors
lead

Whanin Pharmaceutical Company

INDUSTRY

NCT06154434 - Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets | Biotech Hunter | Biotech Hunter